Prior to vaccine availability, RSV was a significant cause of illness and hospitalization in older adults in the U.S., ...

Older adults' immune systems naturally weaken with age, making them more susceptible to COVID-19, influenza (flu) and RSV. Here's what you need to know about these respiratory viruses and why ...

The respiratory syncytial virus (RSV) vaccine produced strong immune responses in older adults during its first two seasons of use, according to a new study.

The NHS has begun inviting older people in Oxfordshire to receive their respiratory syncytial virus (RSV) vaccine.

The respiratory syncytial virus (RSV) vaccine triggered strong immune responses among people aged 60 years and older during ...

A vaccination program in Scotland has significantly reduced hospital admissions for a common respiratory virus among older adults. A new study from the University of Strathclyde and Public Health ...

A new study has found a major drop in respiratory syncytial virus (RSV) related hospitalisations following vaccination ...

The new study, published in The Lancet Infectious Diseases, is the first to give evidence of the impact of the RSV vaccination program and underlines the importance of older adults coming forward ...